Cargando…
Posaconazole-induced hypertension and hypokalemia due to inhibition of the 11β-hydroxylase enzyme
Posaconazole is an antifungal therapy reported to cause incident hypertension. Hypokalemia is also a known side effect. The combination of hypertension and hypokalemia suggests mineralocorticoid excess. We present the case of a 15-year-old adolescent male with hypertensive urgency while on prophylac...
Autores principales: | Barton, Kevin, Davis, T Keefe, Marshall, Bess, Elward, Alexis, White, Neil H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165748/ https://www.ncbi.nlm.nih.gov/pubmed/30289132 http://dx.doi.org/10.1093/ckj/sfx156 |
Ejemplares similares
-
Unravelling drug-induced hypertension: molecular mechanisms of aldosterone-independent mineralocorticoid receptor activation by posaconazole
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2018) -
Heroin crystal nephropathy
por: Bautista, Josef Edrik Keith, et al.
Publicado: (2015) -
Metabolic adaptability in hexavalent chromium-treated renal tissue: an in vivo study
por: Shil, Kanu, et al.
Publicado: (2018) -
Chronic exposure to cadmium is associated with a marked reduction in glomerular filtration rate
por: Satarug, Soisungwan, et al.
Publicado: (2018) -
Is renal tubular cadmium toxicity clinically relevant?
por: Boonprasert, Kanyarat, et al.
Publicado: (2018)